Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
Alcresta Therapeutics, Inc.
|
D/A | 2016-10-31 16:43:21 |
Amount To Be Raised
$50,889,675
Associated Brokers / Dealers
N/A
CIK Number
0001673510
Filed Document
0001140361-16-084182
Exclusions or Exemptions
506b
Accepted Date
2016-10-31 16:43:21
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Alcresta Therapeutics, Inc.
|
D | 2017-09-25 14:42:43 |
Amount To Be Raised
$34,999,978
Associated Brokers / Dealers
N/A
CIK Number
0001673510
Filed Document
0001673510-17-000002
Exclusions or Exemptions
506b
Accepted Date
2017-09-25 14:42:43
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Alcresta, Inc.
|
D | 2016-06-14 15:56:31 |
Amount To Be Raised
$49,389,680
Associated Brokers / Dealers
N/A
CIK Number
0001673510
Filed Document
0001140361-16-069707
Exclusions or Exemptions
506b
Accepted Date
2016-06-14 15:56:31
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Alcresta Therapeutics, Inc.
|
D | 2020-03-03 13:46:00 |
Amount To Be Raised
$19,999,998
Associated Brokers / Dealers
N/A
CIK Number
0001673510
Filed Document
0001673510-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-03-03 13:46:00
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Alcresta Therapeutics, Inc.
|
D | 2019-01-23 10:51:16 |
Amount To Be Raised
$25,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001673510
Filed Document
0001673510-19-000001
Exclusions or Exemptions
506b
Accepted Date
2019-01-23 10:51:16
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|